<DOC>
	<DOCNO>NCT00169091</DOCNO>
	<brief_summary>This study examine physical response bring clozapine haloperidol people experience first episode schizophrenia .</brief_summary>
	<brief_title>Clozapine Versus Haloperidol Treating First Episode Schizophrenia</brief_title>
	<detailed_description>This longitudinal double blind , 2- 5 year study clinical , neuroendocrine biochemical response clozapine ( CLOZ ) haloperidol ( HAL ) group `` first episode '' schizophrenic ( RDC ) patient . Within protocol , compare differential effect two drug short term ( 12 week ) long-term ( 2-5 year ) ; evaluate relationship change prolactin level clinical response patient ; search biochemical predictor correlate clinical response . To achieve study aim , employ drug-washout period , 12-week acute treatment period ; 88 - 260 week follow-up period .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Haloperidol</mesh_term>
	<mesh_term>Haloperidol decanoate</mesh_term>
	<mesh_term>Clozapine</mesh_term>
	<criteria>RDC diagnosis schizophrenia Men woman , without regard race/ethnicity , Aged 1845 Acutely psychotic score least 3 one psychotic scale item Brief Psychiatric Rating Scale ( BPRS ) ( hallucination , delusion , conceptual disorganization ) total BPRS &gt; 21 ( 0 6 scale ) ; Require treatment neuroleptic drug clinical basis ; The patient ( patient 's authorized legal representative ) must understand nature study sign inform consent ; Be within first episode psychotic disorder ; Have history neuroleptic treatment &lt; 12 week ; Likely remain study 2 year . Substance dependence last six month History seizure blood dyscrasia Major medical illness Pregnancy Lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Clozapine</keyword>
	<keyword>Haloperidol</keyword>
	<keyword>Schizophrenia</keyword>
</DOC>